Filing Analysis
Ribbon Acquisition Corp. has deposited $125,000 into its trust account to secure a one-month extension for its deadline to complete an initial business combination. The new deadline to consummate a merger or acquisition is October 15, 2026.
🚩 Red Flags
- The company is a SPAC (Special Purpose Acquisition Company) seeking extensions, which indicates it has not yet found a target or completed a merger by the original deadline.
📋 Key Facts
- An aggregate of $125,000 (the 'Extension Payment') was deposited into the trust account on August 11, 2026.
- The extension period is for one month.
- The new deadline to consummate the initial business combination is October 15, 2026 (previously September 15, 2026).
- The company is an emerging growth company.
Ribbon Acquisition Corp. has announced the rescheduling of its Extraordinary General Meeting of Shareholders from September 14, 2026, to November 14, 2026.
🚩 Red Flags
- Delay in shareholder meeting for a SPAC (Special Purpose Acquisition Company) can sometimes indicate delays in closing a business combination or difficulties in securing sufficient votes.
📋 Key Facts
- The Extraordinary General Meeting was originally scheduled for September 14, 2026.
- The meeting is now rescheduled to November 14, 2026, at 10:00 a.m. ET.
- The Record Date for voting remains February 18, 2026.
- Proxies previously submitted will remain valid for the adjourned meeting unless revoked.
Ribbon Acquisition Corp. entered into a complex suite of financing agreements with Meteora Select Trading Opportunities Master, LP, including a Forward Purchase Agreement, a $100M Standby Equity Purchase Agreement (SEPA), and a Convertible Promissory Note. These agreements are structured to fund the company following its upcoming business combination with DRC Medicine Ltd.
🚩 Red Flags
- Highly dilutive financing structures (SEPA and Forward Purchase Agreement).
- Convertible Note with significant penalties (18% default interest and 7% payment premium).
- Investor holds a Right of First Refusal (ROFR) on 33% of future financings, potentially limiting other capital sources.
- The SEPA includes a 'death spiral' characteristic where shares are purchased at a discount to market price.
- Escrow agreement allows for transfer of 9.9% of PubCo shares to the Investor upon an event of default on the Note.
📋 Key Facts
- Entered into a Forward Purchase Agreement for up to 4,100,000 shares of PubCo common stock.
- Entered into a $100,000,000 Standby Equity Purchase Agreement (SEPA) with a 36-month commitment period.
- SEPA allows Investor to purchase shares at a discount (generally 97% of market price).
- Issued a Convertible Promissory Note with an initial $1,212,121 principal amount and a 17.5% original issue discount.
- The Note bears 18% interest in the event of default and includes a 7% payment premium.
- Investor granted a right of first refusal to invest in up to 33% of any future debt or equity financing.
- Contains a provision where 33% of net proceeds from certain future financings must be used to repay the Note.
Ribbon Acquisition Corp. has deposited $125,000 into its trust account to secure a one-month extension for completing its initial business combination. The new deadline to consummate the transaction is September 15, 2026.
🚩 Red Flags
- SPAC deadline extension: The company is approaching its deadline to complete a business combination, which is a common precursor to liquidation if a target is not found.
- Short extension duration: A one-month extension is relatively brief, suggesting urgency in finding a target or finalizing a deal.
📋 Key Facts
- Extension Payment of $125,000 deposited on August 11, 2026.
- The extension period is for one month.
- The new deadline to consummate the initial business combination is September 15, 2026 (extended from August 15, 2026).
- The company is a SPAC (Special Purpose Acquisition Company) listed on Nasdaq.
Ribbon Acquisition Corp. has deposited $125,000 into its trust account to secure a one-month extension for completing its initial business combination. The new deadline to consummate the transaction is August 15, 2026.
🚩 Red Flags
- SPAC extension activity often indicates difficulty in finding a target or closing a deal within the original timeframe.
- Short-term extension (only one month) suggests an urgent need to finalize a transaction.
📋 Key Facts
- Extension Payment amount: $125,000
- New expiration date for business combination: August 15, 2026
- Previous expiration date: July 15, 2026
- The payment was deposited into the trust account for public shareholders.
Ribbon Acquisition Corp. (a SPAC) entered into a definitive Business Combination Agreement on June 30, 2025, to merge with DRC Medicine Inc., a company specializing in AI-powered allergy and infection diagnostic kits and protective face masks.
🚩 Red Flags
- SPAC transaction complexity involving multiple jurisdictions (Cayman Islands, Japan, Delaware).
- Redemption risk: The final share count depends on the 'Redemption Price' at closing, which is subject to shareholder redemptions.
📋 Key Facts
- Agreement date: June 30, 2025
- Target Company: DRC Medicine Inc. (Delaware) and DRC Medicine Ltd. (Japan)
- Transaction Structure: Share exchange followed by domestication from Cayman Islands to Delaware, then a merger with a subsidiary of PubCo.
- Equity Value: The Aggregate Merger Consideration is based on an equity value of $350,000,000.
- Consideration Ratio: To be determined by dividing the Equity Value by the Redemption Price at the time of closing.
- Target Business: Design and manufacture of AI-powered allergy/infection diagnostic kits and protective face masks.
Ribbon Acquisition Corp. has announced the separation of its units into Class A ordinary shares and rights, which began trading on March 7, 2025. This allows unit holders to trade the underlying components separately under new Nasdaq symbols.
📋 Key Facts
- Units (RIBBU) consist of one Class A Ordinary Share and one Right.
- Class A Ordinary Shares are now trading under symbol 'RIBB' on Nasdaq.
- Rights are now trading under symbol 'RIBBR' on Nasdaq, with each right entitling the holder to 1/7th of a Class A Ordinary Share.
- Trading for separated components commenced on March 7, 2025.
- Unit holders must contact transfer agent Odyssey Trust Company to separate units.
Ribbon Acquisition Corp. successfully consummated its initial public offering (IPO) and a simultaneous private placement on January 16, 2025. The company raised gross proceeds of $50 million from the public and $2.2 million from its sponsor.
📋 Key Facts
- Consummated IPO of 5,000,000 units at $10.00 per unit on January 16, 2025.
- Public Unit composition: One Class A ordinary share and one Right (entitling holder to 1/7 of an Ordinary Share).
- Private placement of 220,000 units with Sponsor (Ribbon Investment Company Ltd) at $10.00 per unit.
- Total gross proceeds from IPO and Private Placement: $52,200,000.
- $50,000,000 of net proceeds deposited into a trust account with Odyssey Trust Company.
Ribbon Acquisition Corp. has successfully completed its initial public offering (IPO) and private placement, raising a total of $52.2 million in gross proceeds. The company is a SPAC (Special Purpose Acquisition Company) that has established a trust account to fund a future business combination.
🚩 Red Flags
- SPAC structure inherently carries high risk regarding the ultimate target identification and business combination success.
📋 Key Facts
- Completed IPO of 5,000,000 units at $10.00 per unit, generating $50,000,000 in gross proceeds.
- Consummated private placement of 220,000 units with Sponsor (Ribbon Investment Company Ltd) at $10.00 per unit, generating $2,200,000.
- Total net proceeds deposited into a trust account as of January 16, 2025, is $50,000,000 (net IPO/Private Placement funds).
- Each Public Unit consists of one Class A ordinary share and one right to receive 1/7th of an ordinary share upon business combination.
- Appointed three new directors: James Zhao-Hui Zhang, Kani Chen, and Jon Nathan Miller.